Low Dose Naltrexone : The Next Miracle Drug?

by Michael D. Shaw, Exec VP, Interscan Corporation

"LDN is inexpensive with virtually no harmful side effects. However, since it is no longer a proprietary drug, the pace of rolling out clinical trials for the off-label effects described in this article will probably be slow, as will its acceptance by mainstream medicine. Still, there is nothing to prevent a patient from taking an FDA approved drug for an off-label indication, and this practice goes on all the time.

Certainly, there is much appeal in a naturally-acting immune modulator that is cheap and effective. We await the publication of further results."

http://www.dentalplans.com/articles/42637/low-dose-naltrexone-the-next-miracle-drug.html

UK Low Dose Naltrexone (LDN) NHS Trial Petition Surpasses 2,500 Signatures

The petition on the UK Number 10 Government petition web site to request a Low Dose Naltrexone (LDN) NHS-funded clinical trial

has now surpassed 2,500 signatures.

In order to be seriously considered by the UK government, this petition will need to reach 15,000 signatures by 23rd November

this year.

If you are a UK citizen, or know one, please spread the word about this important petition.

If you have already signed it, please pass it on to anyone you know who can sign and please ask them to do the same.

The election of the BNP to the European Parliament demonstrates, albeit in an unpleasant way, how a small number of people can

instigate change - Please use your power to help this petition change the way that Low Dose Naltrexone (LDN) is used in the UK

National Health Service and help the millions of people who could benefit from access to this drug move a step closer to the 

opportunity to gain relief from their daily suffering.

Thank you.

http://petitions.number10.gov.uk/LowDNaltrexone/

MS Patient Blog - Improvement Continuing Using Low Dose Naltrexone (LDN)

Julie Stachowiak, Ph.D., writing in her about.com blog - She continues to show improvement in her Multiple Sclerosis symptoms due to treatment with Low Dose Naltrexone (LDN) -

http://ms.about.com/b/2009/06/03/julies-low-dose-naltrexone-journal-month-15.htm

Interview with Dr Burton Berkson on Low Dose Naltrexone (LDN) for Cancer Treatment

http://preview.tinyurl.com/pju6mu